http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109082412-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56905 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20 |
filingDate | 2018-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-109082412-B |
titleOfInvention | Monoclonal antibody of toxoplasma clavuligerus protein ROP18, cell strain secreting antibody and application of monoclonal antibody |
abstract | The invention discloses a monoclonal antibody of a toxoplasma clavuligerum protein ROP18, a cell strain secreting the antibody and application thereof, wherein the monoclonal antibody cell strain of the toxoplasma clavuligerum protein ROP18 is a hybridoma cell strain T2 which is preserved by China center for type culture Collection with the address: china, Wuhan university, the preservation number is CCTCC NO: c2018115, the preservation date is 7 months and 20 days in 2018. The monoclonal antibody of the toxoplasma clavuligerum protein ROP18 is secreted by the hybridoma cell strain T2 and can be used for preparing a reagent for detecting the toxoplasma clavuligerum protein 18 antigen. The invention prepares a mouse-derived toxoplasma clavuligerus protein ROP18 monoclonal antibody cell strain T2 by a cell fusion technology, and the monoclonal antibody secreted by the cell strain is screened by an indirect competitive enzyme-linked immunosorbent assay and preliminarily identified by an epitope, thereby laying a foundation for further clinical application. |
priorityDate | 2018-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.